Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19.

Enrique J. deAndrés-Galiana Juan Luis Fernández Martínez Óscar Álvarez-Machancoses Guillermina Bea Carlos M. Galmarini Andrzej Kloczkowski Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19. 106029 2022 149 Comput. Biol. Medicine https://doi.org/10.1016/j.compbiomed.2022.106029 db/journals/cbm/cbm149.html#deAndres-Galiana22